BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,522,000 | -51.5% | 28,257 | -42.2% | 0.29% | -48.2% |
| Q2 2022 | $3,138,000 | +2.6% | 48,853 | +23.8% | 0.55% | +18.6% |
| Q1 2022 | $3,059,000 | -0.4% | 39,456 | +10.3% | 0.47% | 0.0% |
| Q4 2021 | $3,072,000 | +23.1% | 35,784 | +15.3% | 0.47% | -1.1% |
| Q3 2021 | $2,496,000 | +10.9% | 31,029 | -10.9% | 0.47% | -47.8% |
| Q4 2017 | $2,251,000 | +0.6% | 34,828 | -2.4% | 0.90% | -5.0% |
| Q3 2017 | $2,238,000 | +3.6% | 35,673 | 0.0% | 0.95% | -1.8% |
| Q2 2017 | $2,160,000 | -42.6% | 35,673 | -50.8% | 0.97% | -44.5% |
| Q1 2017 | $3,761,000 | +14.6% | 72,519 | -2.0% | 1.75% | +11.1% |
| Q4 2016 | $3,282,000 | +4.3% | 74,018 | -3.4% | 1.57% | -0.8% |
| Q1 2016 | $3,147,000 | +6.3% | 76,598 | -1.3% | 1.59% | +0.2% |
| Q4 2015 | $2,961,000 | +13.1% | 77,619 | -2.6% | 1.58% | +8.8% |
| Q3 2015 | $2,619,000 | -55.5% | 79,719 | -2.0% | 1.46% | -58.0% |
| Q2 2014 | $5,884,000 | -1.1% | 81,385 | +0.7% | 3.46% | -5.5% |
| Q1 2014 | $5,947,000 | +28.3% | 80,830 | +21.3% | 3.67% | +21.8% |
| Q4 2013 | $4,636,000 | +20.2% | 66,650 | +13.5% | 3.01% | +11.0% |
| Q3 2013 | $3,856,000 | -4.8% | 58,700 | +0.4% | 2.71% | -11.7% |
| Q2 2013 | $4,051,000 | – | 58,475 | – | 3.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |